[News Brief] Fangzhou Launches Once-Weekly Diabetes Combination Therapy in China
Fangzhou Inc. has launched Novo Nordisk’s Kyinsu® on its Internet hospital platform in China, making the once-weekly basal insulin and…
Asia PR
[News Brief] OTR Therapeutics and LG Chem Partner to Advance Oncology Assets
OTR Therapeutics and LG Chem have entered into a strategic framework agreement to identify, evaluate and develop novel oncology assets…
[News Brief] Tanabe Divests Manufacturing Unit to Towa Pharmaceutical
Tanabe Pharmaceutical has agreed to sell its domestic manufacturing subsidiary, Tanabe Pharma Factory, to Towa Pharmaceutical as part of a…
[News Brief] Lotus Pharma Commences South Korean Distribution of Uro-Vaxom
Lotus Pharmaceutical has announced that its subsidiary, Alvogen Korea, has commenced distribution of Uro-Vaxom in South Korea following an agreement…
[News Brief] REPROCELL Seeks Japan Approval for Stem Cell Therapy
REPROCELL has submitted an application for manufacturing and marketing approval in Japan for Stemchymal, a regenerative medicine product intended to…
[News Brief] Sanyou Bio and Baiyunshan Xihe Partner on Radiopharmaceutical Development
Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have signed a strategic collaboration agreement to co-develop radiopharmaceutical and radiodiagnostic products…
[News Brief] Mahidol University Partners with WE-WIN on Pharmaceutical Research
Mahidol University’s Faculty of Pharmacy and Taiwan’s WE-WIN Bio-Medical Co., Ltd. have signed a memorandum of understanding to strengthen collaboration…
[News Brief] DKSH Partners with Lilly in Hong Kong and Macau
DKSH Business Unit Healthcare has entered into a distribution and promotion agreement with Eli Lilly Export S.A. to sell, promote…
[News Brief] CanSinoBIO Receives Argentine Approval for Meningococcal Vaccine
CanSino Biologics Inc. has received a drug registration certificate from Argentina’s Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT)…
[News Brief] Anixa Biosciences Secures South Korean Patent for Breast Cancer Vaccine
Anixa Biosciences has announced that the Korean Ministry of Intellectual Property has granted a composition-of-matter patent for its breast cancer…